AzTrials
AzTrials

Research institution

Mayo Clinic Clinical Trials

Studies where Mayo Clinic is the lead sponsor: what is enrolling now, by phase, condition and country.

3,263 registered studies

In numbers

Open to volunteers
670
Active
820
With results posted
717
All registered
3,263

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 670
  • Preeclampsia

    Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

    • Recruiting
    • Age: 18 to 50 years
    • Phase 2
    • Injection or infusion

    The researchers are testing a medication named ravulizumab for the treatment of severe preeclampsia and Hemolysis, Elevated Liver enzymes, Low Platelets (HELLP) syndrome.

    Trial name
    NCT06333652
    Testing
    Ravulizumab
    Where
    United States
    Volunteers
    14 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT06333652
  • Fibromuscular Dysplasia, Spontaneous Coronary Artery Dissection

    A Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia

    • Recruiting
    • Age: 21 to 65 years
    • Lifestyle or therapy programme

    The purpose of this study is to assess the cardiopulmonary, hemodynamic, and symptom responses to acute bouts of varying intensity aerobic and resistance exercise in people with Spontaneous Coronary Artery Dissection (SCAD)…

    Trial name
    NCT07526766
    Testing
    Aerobic and resistance exercises
    Where
    United States
    Volunteers
    28 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT07526766
  • Cervical Carcinoma

    A Community Based Intervention to Improve Cervical Cancer Screening Among Women in the Hispanic and East African Immigrant Community

    • Recruiting
    • Age: 30 to 65 years
    • Surgery or procedure
    • Lifestyle or therapy programme

    This clinical trial studies whether a community based intervention improves cervical cancer screening (CCS) among women in the Hispanic and East African immigrant community.

    Trial name
    NCT07890402
    Testing
    HPV Self-Collection, Informational Intervention, Interview
    Where
    United States
    Volunteers
    118 people, healthy volunteers welcome
    Sponsor
    Mayo Clinic
    Can I take part? NCT07890402
  • Obesity

    Weight Loss Through Mayo Clinic Diet

    • Recruiting
    • Age: 18 to 64 years
    • Lifestyle or therapy programme

    The purpose of study is to evaluate the efficacy of the Mayo Clinic Diet in clinically significant weight loss (>5%) versus usual care.

    Trial name
    NCT06862375
    Testing
    Mayo Clinic Diet, Usual Care
    Where
    United States
    Volunteers
    250 people, healthy volunteers welcome
    Sponsor
    Mayo Clinic
    Can I take part? NCT06862375
  • Vulvar Intraepithelial Neoplasia, HPV-Independent, Vulvar Squamous Cell Carcinoma

    Evaluation of a Point-of-Care, AI-Powered Spectroscopy Device for Triage of Suspicious Vulvar Lesions: A Pilot Study

    • Recruiting
    • Age: 18 years and older
    • Observational study

    This purpose of this study is to assess the feasibility of using the DermaSensor™ device on vulvar skin.

    Conditions
    Vulvar Intraepithelial Neoplasia, HPV-Independent, Vulvar Squamous Cell Carcinoma, Vulvar Squamous Intraepithelial Lesion, HPV-Associated
    Trial name
    NCT07886203
    Testing
    Non-Interventional Study
    Where
    United States
    Volunteers
    20 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT07886203
  • Malignant Solid Neoplasm, Chronic Lymphocytic Leukemia

    Wisconsin Ginseng for Decreasing Cancer Related Fatigue

    • Recruiting
    • Age: 18 years and older
    • Phase 3

    This phase III trial compares the effect of Wisconsin ginseng (panax quinquefolius) to placebo in patients with cancer that suffer from significant fatigue.

    Conditions
    Malignant Solid Neoplasm, Chronic Lymphocytic Leukemia, Hematopoietic and Lymphatic System Neoplasm, Hodgkin Lymphoma
    Trial name
    NCT06395441
    Testing
    American Ginseng, Questionnaire Administration
    Where
    15 sites in United States
    Volunteers
    222 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT06395441
  • Large B-Cell Lymphoma With IRF4 Rearrangement, Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma

    Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

    • Recruiting
    • Age: 18 years and older
    • Phase 2
    • Pill or oral medicine
    • Injection or infusion

    This phase II trial tests the effectiveness of golcadomide and rituximab as bridging treatment before chimeric antigen receptor (CAR) T-cell therapy in patients with aggressive B-cell non-Hodgkin lymphoma that has come back after…

    Conditions
    Large B-Cell Lymphoma With IRF4 Rearrangement, Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma, Recurrent ALK-Positive Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
    Trial name
    NCT06834373
    Testing
    Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy
    Where
    7 sites in United States
    Volunteers
    41 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT06834373
  • Diffuse Alveolar Hemorrhage, Antineutrophil Cytoplasmic Antibody Positive Vasculitis

    Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube

    • Recruiting
    • Age: 18 years and older
    • Phase 1
    • Pill or oral medicine

    The purpose of this study is to determine the 72-hour pharmacokinetics of emulsified avacopan at a dose of 30 mg twice daily given to up to 6 patients with active severe GPA or MPA with diffuse alveolar hemorrhage (DAH) requiring…

    Trial name
    NCT07556484
    Testing
    Avacopan
    Where
    United States
    Volunteers
    6 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT07556484
  • Grief

    Accelerated Resolution Therapy for Early Maladaptive Grief

    • Recruiting
    • Age: 55 years and older
    • Lifestyle or therapy programme

    The purpose study is to test the effects of accelerated resolution therapy (ART) on pre-loss grief and prolonged grief disorder among older adult family caregivers (FCGs).

    Trial name
    NCT05624879
    Testing
    Accelerated Resolution Therapy, Information and Support
    Where
    4 sites in United States
    Volunteers
    440 people, healthy volunteers welcome
    Sponsor
    Mayo Clinic
    Can I take part? NCT05624879
  • Pharmacogenomic Drug Interaction, Side Effect of Drug

    Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:

    • Recruiting
    • Age: 18 years and older
    • Phase 2

    The purpose of this study is to determine whether the implementation of pre-emptive pharmacogenomic (PGx) testing of a panel of clinically relevant PGx markers, to guide the dose and drug selection for 39 commonly prescribed…

    Conditions
    Pharmacogenomic Drug Interaction, Side Effect of Drug, Ineffective Drug Action, Drug Metabolism, Poor, CYP2D6-Related
    Trial name
    PREPARE-Mayo (NCT06322238)
    Testing
    PGx panel test
    Where
    United States
    Volunteers
    66 people, healthy volunteers welcome
    Sponsor
    Mayo Clinic

Completed, with results posted

All –
  • Cesarean Delivery

    Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery

    • Completed
    • Age: 18 years and older
    • Phase 4
    • Injection or infusion
    • Results posted

    The purpose of this study is to determine if there is a difference in opioid requirements at 0-48 hours after scheduled cesarean delivery in patients receiving 150 mcg intrathecal morphine compared to 0.2 mg/kg (maximum 20 mg)…

    Trial name
    NCT06826742
    Testing
    Intravenous line (IV) Methadone, Intrathecal Morphine
    Where
    United States
    Volunteers
    30 people, healthy volunteers welcome
    Sponsor
    Mayo Clinic
    Can I take part? NCT06826742
  • Isolated Aortic Stenosis, Mitral Regurgitation

    A Study to Evaluate a Computerized Stethoscope Called ©Voqx to Diagnose Heart Disease

    • Completed
    • Age: 18 years and older
    • Medical device
    • Results posted

    The purpose of this study is to determine whether recording heart sounds with an acoustic stethoscope, combined with artificial intelligence (computer information), will show similar abnormalities to an echocardiogram or cardiac…

    Trial name
    NCT04960280
    Testing
    ©VoqX stethoscope
    Where
    United States
    Volunteers
    400 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT04960280
  • Cirrhosis

    A Study to Detect Advanced Liver Disease Via AI-enabled Electrocardiogram

    • Completed
    • Age: 18 years and older
    • Medical device
    • Results posted

    The overall objectives of this study are to determine the effectiveness of ACE 2.0 model in early detection of advanced liver fibrosis, and to determine the acceptance and barriers for use of an AI-enabled algorithm for…

    Trial name
    ADVANCE (NCT05782283)
    Testing
    ACE (AI-Cirrhosis-ECG) 2.0
    Where
    United States
    Volunteers
    248 people
    Sponsor
    Mayo Clinic
    Can I take part? ADVANCE
  • Irritable Bowel Syndrome

    Comparison of Rimegepant and Placebo for Pain in IBS

    • Completed
    • Age: 18 to 70 years
    • Phase 2
    • Pill or oral medicine
    • Results posted

    The primary aim of this study is to evaluate the efficacy of rimegepant on abdominal pain scores in participants with non-constipation IBS.

    Trial name
    NCT06221111
    Testing
    Rimegepant 75 MG [Nurtec]
    Where
    United States
    Volunteers
    39 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT06221111
  • Cardiomyopathy

    AI-SCREENDCM Decentralized Clinical Trial - Pilot Study

    • Completed
    • Age: 18 years and older
    • Results posted

    The purpose of this study is to assess the feasibility and impact of screening FDR of DCM probands using a mobile ECG with the ability to transmit the ECG for cloud-based AI analysis to detect reduced left ventricular ejection…

    Trial name
    NCT06609174
    Testing
    KardiaRx ECG Screening and AI interpretation of ECG
    Where
    United States
    Volunteers
    119 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT06609174

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in